Weinhaupl K, Meuret L, Desrat S, Roussi F, Roussy F, Morellet N
Sci Rep. 2025; 15(1):4146.
PMID: 39900984
PMC: 11791199.
DOI: 10.1038/s41598-025-87535-1.
Dash R, Liu Z, Lepori I, Chordia M, Ocius K, Holsinger K
bioRxiv. 2025; .
PMID: 39868157
PMC: 11760776.
DOI: 10.1101/2025.01.17.633618.
Presloid C, Jiang J, Kandel P, Anderson H, Beardslee P, Swayne T
Mol Microbiol. 2024; 123(1):16-30.
PMID: 39626090
PMC: 11717620.
DOI: 10.1111/mmi.15334.
Sussmuth R, Sussmuth R, Kulike-Koczula M, Kulike-Koczula M, Gao P, Kosol S
Angew Chem Int Ed Engl. 2024; 64(10):e202414325.
PMID: 39611429
PMC: 11878372.
DOI: 10.1002/anie.202414325.
Fei F, Lun S, Saxena A, Raghavan M, DeRisi J, Bishai W
Org Lett. 2024; 26(45):9698-9703.
PMID: 39486397
PMC: 11574846.
DOI: 10.1021/acs.orglett.4c03473.
ApoE Mimetic Peptide COG1410 Kills via Directly Interfering ClpC's ATPase Activity.
Wang C, Ren Y, Han L, Yi P, Wang W, Zhang C
Antibiotics (Basel). 2024; 13(3).
PMID: 38534713
PMC: 10967448.
DOI: 10.3390/antibiotics13030278.
The Antitubercular Activities of Natural Products with Fused-Nitrogen-Containing Heterocycles.
Boshoff H, Malhotra N, Barry 3rd C, Oh S
Pharmaceuticals (Basel). 2024; 17(2).
PMID: 38399426
PMC: 10892018.
DOI: 10.3390/ph17020211.
BacPROTACs targeting Clp protease: a promising strategy for anti-mycobacterial drug discovery.
Bonjorno A, Pavan A, Fernandes G, Scarim C, Castagnolo D, Dos Santos J
Front Chem. 2024; 12:1358539.
PMID: 38357296
PMC: 10864484.
DOI: 10.3389/fchem.2024.1358539.
Metabolites from (VTCC43181) and Their Inhibition of ClpC1 Protein.
Tran T, Huynh N, Pham N, Nguyen D, Tran C, Nguyen U
Molecules. 2024; 29(3).
PMID: 38338462
PMC: 10856564.
DOI: 10.3390/molecules29030720.
Therapeutic Potential of Marine-Derived Cyclic Peptides as Antiparasitic Agents.
Ribeiro R, Costa L, Pinto E, Sousa E, Fernandes C
Mar Drugs. 2023; 21(12).
PMID: 38132930
PMC: 10745025.
DOI: 10.3390/md21120609.
Targeting bacterial degradation machinery as an antibacterial strategy.
Petkov R, Camp A, Isaacson R, Torpey J
Biochem J. 2023; 480(21):1719-1731.
PMID: 37916895
PMC: 10657178.
DOI: 10.1042/BCJ20230191.
Interactome Analysis Identifies MSMEI_3879 as a Substrate of Mycolicibacterium smegmatis ClpC1.
Ogbonna E, Anderson H, Beardslee P, Bheemreddy P, Schmitz K
Microbiol Spectr. 2023; 11(4):e0454822.
PMID: 37341639
PMC: 10433963.
DOI: 10.1128/spectrum.04548-22.
cell-wall and antimicrobial peptides: a mission impossible?.
Jacobo-Delgado Y, Rodriguez-Carlos A, Serrano C, Rivas-Santiago B
Front Immunol. 2023; 14:1194923.
PMID: 37266428
PMC: 10230078.
DOI: 10.3389/fimmu.2023.1194923.
Bioinformatic identification of ClpI, a distinct class of Clp unfoldases in Actinomycetota.
Jiang J, Schmitz K
Front Microbiol. 2023; 14:1161764.
PMID: 37138635
PMC: 10149685.
DOI: 10.3389/fmicb.2023.1161764.
Molecular Characterization of the ClpC AAA+ ATPase in the Biology of Chlamydia trachomatis.
Pan S, Jensen A, Wood N, Henrichfreise B, Brotz-Oesterhelt H, Fisher D
mBio. 2023; 14(2):e0007523.
PMID: 36975997
PMC: 10128030.
DOI: 10.1128/mbio.00075-23.
ClpC2 protects mycobacteria against a natural antibiotic targeting ClpC1-dependent protein degradation.
Taylor G, Cui H, Leodolter J, Giese C, Weber-Ban E
Commun Biol. 2023; 6(1):301.
PMID: 36944713
PMC: 10030653.
DOI: 10.1038/s42003-023-04658-9.
Identification of the inhibitory mechanism of ecumicin and rufomycin 4-7 on the proteolytic activity of Mycobacterium tuberculosis ClpC1/ClpP1/ClpP2 complex.
Hong J, Duc N, Jeong B, Cho S, Shetye G, Cao J
Tuberculosis (Edinb). 2022; 138:102298.
PMID: 36580851
PMC: 9892302.
DOI: 10.1016/j.tube.2022.102298.
A Perspective on Newly Emerging Proteolysis-Targeting Strategies in Antimicrobial Drug Discovery.
Venkatesan J, Murugan D, Rangasamy L
Antibiotics (Basel). 2022; 11(12).
PMID: 36551374
PMC: 9774230.
DOI: 10.3390/antibiotics11121717.
Total Synthesis and Biological Evaluation of Modified Ilamycin Derivatives.
Greve J, Mogk A, Kazmaier U
Mar Drugs. 2022; 20(10).
PMID: 36286456
PMC: 9605216.
DOI: 10.3390/md20100632.
"Upcycling" known molecules and targets for drug-resistant TB.
Roubert C, Fontaine E, Upton A
Front Cell Infect Microbiol. 2022; 12:1029044.
PMID: 36275029
PMC: 9582839.
DOI: 10.3389/fcimb.2022.1029044.
